Akers Biosciences Cmn (AKER) 3.58 $AKER Akers

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akers Biosciences Cmn (AKER) 3.58 $AKER

Akers Biosciences OxiCheck Study Results Positive, Stock Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:21AM CDT
Akers Biosciences Inc. (AKER) recently announced favorable clinical results for its BreathScan OxiCheck disposable breath test.
CAH: 79.67 (-0.05), QDEL: 21.77 (+0.03), AKER: 3.58 (-0.10), NUVA: 65.47 (unch)

Akers Biosciences (AKER) Q2 Loss Narrows Y/Y, Stock Gains
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:16AM CDT
Shares of Akers Biosciences increased almost 3% to close at $3.17 on Aug 11, after the company reported second-quarter 2016 results.
BAX: 46.73 (-0.16), QDEL: 21.77 (+0.03), AKER: 3.58 (-0.10), NUVA: 65.47 (unch)

Akers Biosciences (AKER) Revenues Surge in Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:26AM CDT
Akers Biosciences Inc. (AKER) reported second-quarter product revenues of $$956,486, which increased 28% from the year-ago quarter.
AKER: 3.58 (-0.10)

Akers Biosciences Announces H1 and Q2 2016 Earnings
Marketwire Canada - Thu Aug 11, 6:00AM CDT
Sales of Flagship Rapid HIT Test +68% Over H1 2015 and +57% Over Q2 2015; Conference Call Scheduled for 9:00 a.m. Eastern Time Today
AKER: 3.58 (-0.10)

Akers Biosciences Announces Conference Call to Discuss Q2 2016 Earnings
Marketwired - Tue Aug 09, 10:00AM CDT
THOROFARE, NJ--(Marketwired - Aug 9, 2016) -  Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company", a developer of rapid health information technologies, will hold a conference call on Thursday, August 11, 2016 at 09:00 a.m. Eastern Time to discuss its earnings for the second quarter ended June 30, 2016, which will be published earlier that day. Management will be available during a question-and-answer session.
AKER: 3.58 (-0.10)

Akers Biosciences to Present at LD Micro Invitational Conference
Marketwire Canada - Fri Jun 03, 8:52AM CDT
THOROFARE, NJ--(Marketwired - Jun 3, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) (the "Company", a developer of rapid health information technologies, announces that Co-founder and Chief Scientific Director, Raymond F. Akers, Jr. PhD, will present to investors attending the upcoming LD Micro Invitational Conference in Los Angeles, CA. on Tuesday June 7, 2016. Dr. Akers intends to provide an update on the Company's business including the increasing traction in the US and China of the Company's flagship rapid test for Heparin-induced thrombocytopenia.
AKER: 3.58 (-0.10)

Akers (AKER) Reports Q1 Earnings; Product Revenue Up 79.3%
Aparajita Dutta - Zacks Investment Research - Thu May 12, 7:46AM CDT
Akers' (AKER) first-quarter product revenue increased 79.3% from the year-ago quarter to $738,023
AKER: 3.58 (-0.10)

Akers Biosciences Reports Earnings for Q1 2016
Marketwire Canada - Thu May 12, 6:00AM CDT
PIFA Heparin/PF4 Rapid Tests Sales Up 88%; Total Revenues up 45%
AKER: 3.58 (-0.10), AKR: 36.94 (+0.25)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 3.66 (+0.06), STAA: 8.78 (-0.16), AKER: 3.58 (-0.10), VBLT: 4.11 (+0.08)

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
Marketwire Canada - Wed May 04, 1:00PM CDT
THOROFARE, NJ--(Marketwired - May 4, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company", a developer of rapid health information technologies, is presenting at Joseph Gunnar & Co., LLC's 'Pioneers 2016' conference in New York on May 5, 2016.
AKER: 3.58 (-0.10), AKR: 36.94 (+0.25)

Akers Board Rearrangement
Marketwired - Fri Apr 29, 6:01AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company", a developer of rapid health information technologies, announces changes to the roles of certain board members, which take effect immediately and are designed to improve the effectiveness of the Board of Directors.
AKER: 3.58 (-0.10)

Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 769.16 (+1.58), BAX: 46.73 (-0.16), AKER: 3.58 (-0.10), HRC: 59.31 (-0.21)

Akers Biosciences Reports Earnings for Fiscal Year 2015
Marketwired - Wed Mar 30, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company", a developer of rapid health information technologies, reports its financial results for the fiscal year ended December 31, 2015.
AKER: 3.58 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 175

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 33

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 81

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 50

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 79

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Qfin Holdings Faces Securities Fraud Lawsuit Scrutiny

Updated Category News Views 23

Qfin Holdings Stumbles Under Legal Microscope Picture this—you're riding the stock market wave and then, out of nowhere, your investment gets hit by a sudden drop, leaving you scrambling for answers. That's the scenario investors in Qfin Holdings, Inc. (NASDAQ: QFIN) find themselves in after the company’s stock plunged by nearly 19%. Now, they're not just left...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 39

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Ericsson Completes Major Buyback in November Burst

Updated Category News Views 65

Ericsson's Aggressive Share Repurchase Strategy Ericsson's share buyback spree might not be the first rodeo for seasoned investors out there, but their recent grab between November 9th and 13th surely made a few heads turn. The telecom giant snatched up a neat pile of 500,000 of its own Class B shares, maintaining the steady tick of their ambitious buyback program. It's...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 36

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 95

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading

Top 5 Most Recently Viewed Articles

Birkenstock Holding Q1 Earnings Highlights and Insights

Updated Category News Views 174

Birkenstock Holding Q1 Earnings Overview Birkenstock Holding (NYSE: BIRK) recently shared insights from its first quarter earnings report, showcasing the company’s financial performance and strategic advancements. This update reveals not only earnings results but also highlights on how the company is faring in a competitive market. Earnings Results The company's...

Continue Reading
Kinepolis Group Announces Upcoming Dividend Payment Details

Updated Category News Views 228

Kinepolis Group Dividend Announcement The Kinepolis Group NV is pleased to inform its shareholders of an upcoming dividend payout, a noteworthy event for investors looking to maximize their returns. Dividend Payment Details The company has officially announced a gross dividend of €0.55 per share. After the deduction of the standard 30% withholding tax, shareholders will...

Continue Reading
Celebrating Success: Medical Solutions Recognized in Regionals

Updated Category News Views 144

Celebrating Growth and Achievement for Medical Solutions Recognized for three consecutive years as a leader in healthcare workforce solutions Medical Solutions, a prominent name in healthcare workforce solutions, has been honored once again for its exceptional growth trajectory, being listed among the Midwest's fastest-growing companies. This prestigious recognition marks...

Continue Reading
Unlocking the Future: SEALSQ's MS6003 Secure Element Launch

Updated Category News Views 208

Revolutionizing Secure Authentication with MS6003 SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor innovation, has recently announced a significant addition to its product portfolio: the MS6003 secure element chip. This state-of-the-art chip is equipped with a preloaded FIDO2 application, marking a pivotal step towards enhancing passwordless authentication in an era...

Continue Reading
Navigating Income with High-Dividend Utility Stocks Today

Updated Category News Views 114

Staying Afloat with Utility Stocks In challenging market conditions, many investors search for stability. This leads them to utility stocks, particularly those offering attractive dividend yields. Utilities often provide steady cash flows and dividends, making them appealing for income-seeking investors. Dividend Opportunities in Utilities Sector As the market shifts,...

Continue Reading